Non-alcoholic fatty liver disease (NAFLD): a tale of fat and sugar?

被引：30
|
作者：
Longato, Lisa [1 ]
机构：
[1] UCL, Royal Free Hosp, Inst Liver & Digest Hlth, U3rd Floor,Rowland Hill St, London NW3 2PF, England
来源：
FIBROGENESIS & TISSUE REPAIR | 2013年 / 6卷
关键词：
Fructose; High-fat diet; High-fructose corn syrup; Mice; NAFLD; Non-alcoholic steatohepatitis; Rats; Western diet;
D O I：
10.1186/1755-1536-6-14
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
The global diffusion of the so-called Western diet, which is enriched in fat and carbohydrates, such as fructose, has been proposed to be an underlying cause of the increased prevalence of metabolic conditions, including nonalcoholic fatty liver disease (NAFLD). This Smart Card summarizes the main metabolic and hepatic histological features of rodent models fed with diets combining high fat and fructose.
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Leptin as a marker of liver fibrosis in non-alcoholic fatty liver disease (NAFLD)
    Petrovic, LM
    Alba, LM
    Lindor, KD
    Talwakar, JA
    Angulo, P
    MODERN PATHOLOGY, 2003, 16 (01) : 283A - 283A
  • [32] Liver Biopsy and Non-alcoholic Fatty Liver Disease (NAFLD) in Bariatric Patients
    Kanakala, V.
    Chattopadhyay, D.
    Sarkar, R.
    Balupuri, S.
    Small, P. K.
    BRITISH JOURNAL OF SURGERY, 2015, 102 : 285 - 285
  • [33] Non-alcoholic Fatty Liver Disease (NAFLD) and non-alcoholic Steatohepatitis (NASH): Pathophysiology and Nutritional Aspects
    Schattenberg, Joern M.
    ERNAHRUNGS UMSCHAU, 2015, 62 (02): : M92 - M100
  • [34] In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)
    Kanuri, Giridhar
    Bergheim, Ina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (06): : 11963 - 11980
  • [35] Non-alcoholic fatty liver disease (NAFLD) models in drug discovery
    Cole, Banumathi K.
    Feaver, Ryan E.
    Wamhoff, Brian R.
    Dash, Ajit
    EXPERT OPINION ON DRUG DISCOVERY, 2018, 13 (02) : 193 - 205
  • [36] Non-alcoholic fatty liver disease (NAFLD) among underweight adults
    Fahim, Shah Mohammad
    Chowdhury, Muhammad Abdul Baker
    Alam, Shahinul
    CLINICAL NUTRITION ESPEN, 2020, 38 : 80 - 85
  • [37] Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course
    Cortez-Pinto, H
    Camilo, ME
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2004, 18 (06) : 1089 - 1104
  • [38] Linagliptin is an Effective Therapeutic for Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH)
    Klein, Thomas
    Mark, Michael
    DIABETES, 2012, 61 : A265 - A266
  • [39] Protective Role of Coffee in Non-alcoholic Fatty Liver Disease (NAFLD)
    Catalano, Daniela
    Martines, Giuseppe Fabio
    Tonzuso, Antonia
    Pirri, Clara
    Trovato, Francesca M.
    Trovato, Guglielmo M.
    DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (11) : 3200 - 3206
  • [40] Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD)
    Yoneda, M.
    Fujita, K.
    Inamori, M.
    Nakajima, A.
    Yoneda, M.
    Tamano, M.
    Hiraishi, H.
    GUT, 2007, 56 (09) : 1330 - 1331
12345